Synthesis of collagen I in collagenous sprue

Clin Gastroenterol Hepatol. 2006 Oct;4(10):1232-6. doi: 10.1016/j.cgh.2006.07.003. Epub 2006 Sep 18.

Abstract

Background & aims: Collagenous sprue (CS) is a rare severe malabsorption syndrome of unknown etiology, characterized by villus atrophy and a broad subepithelial collagen band. We studied the expression patterns of genes involved in fibrogenesis and fibrolysis and analyzed the composition of the subepithelial collagen band in CS compared with untreated celiac diseases (CDs).

Methods: Duodenal biopsies from 2 patients with CS were hybridized with (35)S-labeled RNA probes for procollagen alpha1(I), matrix metalloproteinases (MMPs)-1 and -3, and tissue inhibitor of MMP-1 (TIMP-1). Numbers of positive subepithelial and lamina propria cells and grain density per cell were determined microscopically. Immunohistochemistry for collagens I, III, IV, XIV, and tenascin was performed by the immunoalkaline phosphatase method. Findings were compared with earlier data from patients with untreated CD.

Results: Numbers of cells expressing procollagen I, MMP-1, and MMP-3 mRNA were similar, but subepithelial procollagen I transcripts per cell were significantly increased (42 and 38 vs 18 [13-23]; P < .05) in CS compared with CD, whereas cellular transcript densities for MMP-1 and MMP-3 mRNA were similar. In addition, the number of TIMP-1 mRNA-positive cells was higher in CS compared with CD (32 and 25 vs 16.5 [4-25]; P < .05). The subepithelial collagenous bands stained for collagen I, collagen III, and tenascin.

Conclusions: The prominent subepithelial matrix deposition in CS is due to increased expression of the main fibrogenic genes (procollagen I and TIMP-1) by myofibroblastic cells, whereas expression of fibrolytic MMPs remains unaltered.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Biomarkers / metabolism
  • Biopsy
  • Collagen Type I / biosynthesis
  • Collagen Type I / genetics*
  • Duodenum / metabolism
  • Duodenum / pathology*
  • Female
  • Gene Expression*
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / pathology
  • Malabsorption Syndromes / genetics
  • Malabsorption Syndromes / metabolism*
  • Malabsorption Syndromes / pathology
  • Matrix Metalloproteinase 1 / biosynthesis
  • Matrix Metalloproteinase 1 / genetics
  • Matrix Metalloproteinase 3 / biosynthesis
  • Matrix Metalloproteinase 3 / genetics
  • Middle Aged
  • Prognosis
  • RNA, Messenger / genetics
  • Tissue Inhibitor of Metalloproteinase-1 / biosynthesis
  • Tissue Inhibitor of Metalloproteinase-1 / genetics

Substances

  • Biomarkers
  • Collagen Type I
  • RNA, Messenger
  • Tissue Inhibitor of Metalloproteinase-1
  • Matrix Metalloproteinase 3
  • Matrix Metalloproteinase 1